• Something wrong with this record ?

Stereotactic Radiosurgery With Versus Without Neoadjuvant Endovascular Embolization for Brain Arteriovenous Malformations With Associated Intracranial Aneurysms

A. Becerril-Gaitan, J. Nguyen, CC. Lee, D. Ding, CP. Cifarelli, R. Liscak, BJ. Williams, MB. Yusuf, SY. Woo, RE. Warnick, DM. Trifiletti, D. Mathieu, D. Kondziolka, CE. Feliciano, R. Rodriguez-Mercado, KM. Cockroft, S. Simon, J. Lee, JP. Sheehan,...

. 2025 ; 96 (4) : 787-793. [pub] 20240822

Language English Country United States

Document type Journal Article, Comparative Study

Persistent link   https://www.medvik.cz/link/bmc25009403

BACKGROUND AND OBJECTIVES: Stereotactic radiosurgery (SRS) with neoadjuvant embolization is a treatment strategy for brain arteriovenous malformations (AVMs), especially for those with large nidal volume or concomitant aneurysms. The aim of this study was to assess the effects of pre-SRS embolization in AVMs with an associated intracranial aneurysm (IA). METHODS: The International Radiosurgery Research Foundation AVM database from 1987 to 2018 was retrospectively reviewed. SRS-treated AVMs with IAs were included. Patients were categorized into those treated with upfront embolization (E + SRS) vs stand-alone SRS (SRS). Primary end point was a favorable outcome (AVM obliteration + no permanent radiation-induced changes or post-SRS hemorrhage). Secondary outcomes included AVM obliteration, mortality, follow-up modified Rankin Scale, post-SRS hemorrhage, and radiation-induced changes. RESULTS: Forty four AVM patients with associated IAs were included, of which 23 (52.3%) underwent pre-SRS embolization and 21 (47.7%) SRS only. Significant differences between the E + SRS vs SRS groups were found for AVM maximum diameter (1.5 ± 0.5 vs 1.1 ± 0.4 cm 3 , P = .019) and SRS treatment volume (9.3 ± 8.3 vs 4.3 ± 3.3 cm 3 , P = .025). A favorable outcome was achieved in 45.4% of patients in the E + SRS group and 38.1% in the SRS group ( P = .625). Obliteration rates were comparable (56.5% for E + SRS vs 47.6% for SRS, P = .555), whereas a higher mortality rate was found in the SRS group (19.1% vs 0%, P = .048). After adjusting for AVM maximum diameter, SRS treatment volume, and maximum radiation dose, the likelihood of achieving favorable outcome and AVM obliteration did not differ between groups ( P = .475 and P = .820, respectively). CONCLUSION: The likelihood of a favorable outcome and AVM obliteration after SRS with neoadjuvant embolization in AVMs with concomitant IA seems to be comparable with stand-alone SRS, even after adjusting for AVM volume and SRS maximum dose. However, the increased mortality among the stand-alone SRS group and relatively low risk of embolization-related complications suggest that these patients may benefit from a combined treatment approach.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009403
003      
CZ-PrNML
005      
20250429134752.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1227/neu.0000000000003152 $2 doi
035    __
$a (PubMed)39171929
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Becerril-Gaitan, Andrea $u Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston , Texas , USA $1 https://orcid.org/0000000346065646
245    10
$a Stereotactic Radiosurgery With Versus Without Neoadjuvant Endovascular Embolization for Brain Arteriovenous Malformations With Associated Intracranial Aneurysms / $c A. Becerril-Gaitan, J. Nguyen, CC. Lee, D. Ding, CP. Cifarelli, R. Liscak, BJ. Williams, MB. Yusuf, SY. Woo, RE. Warnick, DM. Trifiletti, D. Mathieu, D. Kondziolka, CE. Feliciano, R. Rodriguez-Mercado, KM. Cockroft, S. Simon, J. Lee, JP. Sheehan, CJ. Chen, International Radiosurgery Research Foundation, International Radiosurgery Research Foundation
520    9_
$a BACKGROUND AND OBJECTIVES: Stereotactic radiosurgery (SRS) with neoadjuvant embolization is a treatment strategy for brain arteriovenous malformations (AVMs), especially for those with large nidal volume or concomitant aneurysms. The aim of this study was to assess the effects of pre-SRS embolization in AVMs with an associated intracranial aneurysm (IA). METHODS: The International Radiosurgery Research Foundation AVM database from 1987 to 2018 was retrospectively reviewed. SRS-treated AVMs with IAs were included. Patients were categorized into those treated with upfront embolization (E + SRS) vs stand-alone SRS (SRS). Primary end point was a favorable outcome (AVM obliteration + no permanent radiation-induced changes or post-SRS hemorrhage). Secondary outcomes included AVM obliteration, mortality, follow-up modified Rankin Scale, post-SRS hemorrhage, and radiation-induced changes. RESULTS: Forty four AVM patients with associated IAs were included, of which 23 (52.3%) underwent pre-SRS embolization and 21 (47.7%) SRS only. Significant differences between the E + SRS vs SRS groups were found for AVM maximum diameter (1.5 ± 0.5 vs 1.1 ± 0.4 cm 3 , P = .019) and SRS treatment volume (9.3 ± 8.3 vs 4.3 ± 3.3 cm 3 , P = .025). A favorable outcome was achieved in 45.4% of patients in the E + SRS group and 38.1% in the SRS group ( P = .625). Obliteration rates were comparable (56.5% for E + SRS vs 47.6% for SRS, P = .555), whereas a higher mortality rate was found in the SRS group (19.1% vs 0%, P = .048). After adjusting for AVM maximum diameter, SRS treatment volume, and maximum radiation dose, the likelihood of achieving favorable outcome and AVM obliteration did not differ between groups ( P = .475 and P = .820, respectively). CONCLUSION: The likelihood of a favorable outcome and AVM obliteration after SRS with neoadjuvant embolization in AVMs with concomitant IA seems to be comparable with stand-alone SRS, even after adjusting for AVM volume and SRS maximum dose. However, the increased mortality among the stand-alone SRS group and relatively low risk of embolization-related complications suggest that these patients may benefit from a combined treatment approach.
650    _2
$a lidé $7 D006801
650    12
$a radiochirurgie $x metody $x škodlivé účinky $7 D016634
650    12
$a intrakraniální arteriovenózní malformace $x terapie $x chirurgie $7 D002538
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a terapeutická embolizace $x metody $7 D004621
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dospělí $7 D000328
650    _2
$a retrospektivní studie $7 D012189
650    12
$a intrakraniální aneurysma $x terapie $7 D002532
650    12
$a neoadjuvantní terapie $x metody $7 D020360
650    _2
$a výsledek terapie $7 D016896
650    _2
$a endovaskulární výkony $x metody $7 D057510
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Nguyen, Justin $u Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston , Texas , USA
700    1_
$a Lee, Cheng-Chia $u Department of Neurosurgery, Taipei Veterans General Hospital, Taipei , Taiwan $u School of Medicine, National Yan-Ming University, Taipei , Taiwan
700    1_
$a Ding, Dale $u Department of Neurosurgery, University of Louisville, Louisville , Kentucky , USA
700    1_
$a Cifarelli, Christopher P $u Department of Neurosurgery, West Virginia University, Morgantown , West Virginia , USA
700    1_
$a Liscak, Roman $u Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague , Czech Republic
700    1_
$a Williams, Brian J $u Department of Neurosurgery, University of Louisville, Louisville , Kentucky , USA
700    1_
$a Yusuf, Mehran B $u Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham , Alabama , USA
700    1_
$a Woo, Shiao Y $u Department of Radiation Oncology, University of Louisville, Louisville , Kentucky , USA
700    1_
$a Warnick, Ronald E $u Gamma Knife Center, Jewish Hospital, Mayfield Clinic, Cincinnati , Ohio , USA
700    1_
$a Trifiletti, Daniel M $u Department of Radiation Oncology, The Mayo Clinic, Jacksonville , Florida , USA
700    1_
$a Mathieu, David $u Department of Neurosurgery, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke , Quebec , Canada
700    1_
$a Kondziolka, Douglas $u Department of Neurosurgery, New York University Langone Medical Center, New York , New York , USA
700    1_
$a Feliciano, Caleb E $u Department of Neurosurgery, University of Puerto Rico, San Juan , Puerto Rico , USA
700    1_
$a Rodriguez-Mercado, Rafel $u Department of Neurosurgery, University of Puerto Rico, San Juan , Puerto Rico , USA
700    1_
$a Cockroft, Kevin M $u Department of Neurosurgery, Penn State Hershey Medical Center, Hershey , Pennsylvania , USA
700    1_
$a Simon, Scott $u Department of Neurosurgery, Penn State Hershey Medical Center, Hershey , Pennsylvania , USA
700    1_
$a Lee, John $u Department of Neurosurgery, University of Pennsylvania, Philadelphia , Pennsylvania , USA
700    1_
$a Sheehan, Jason P $u Department of Neurosurgery, University of Pennsylvania, Philadelphia , Pennsylvania , USA
700    1_
$a Chen, Ching-Jen $u Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston , Texas , USA $1 https://orcid.org/0000000278309273
710    2_
$a International Radiosurgery Research Foundation
710    2_
$a International Radiosurgery Research Foundation
773    0_
$w MED00003511 $t Neurosurgery $x 1524-4040 $g Roč. 96, č. 4 (2025), s. 787-793
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39171929 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134747 $b ABA008
999    __
$a ok $b bmc $g 2311031 $s 1246484
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 96 $c 4 $d 787-793 $e 20240822 $i 1524-4040 $m Neurosurgery $n Neurosurgery $x MED00003511
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options